The Latest Headlines at American Banking and Market News
ImmunityBio (NASDAQ:IBRX) Price Target Raised to $6.00 at Piper Sandler
ImmunityBio (NASDAQ:IBRX – Free Report) had its target price raised by Piper Sandler from $5.00 to $6.00 in a report released on Monday morning, Benzinga reports. They currently have a neutral rating on the stock. ImmunityBio... More of this article »
InterDigital (NASDAQ:IDCC) Upgraded to “Buy” by StockNews.com
StockNews.com upgraded shares of InterDigital (NASDAQ:IDCC – Free Report) from a hold rating to a buy rating in a research note released on Monday. Separately, Bank of America reaffirmed an underperform rating and set a $100.00... More of this article »
Horizon Bancorp (NASDAQ:HBNC) Given New $13.00 Price Target at Piper Sandler
Horizon Bancorp (NASDAQ:HBNC – Free Report) had its price objective cut by Piper Sandler from $14.00 to $13.00 in a research note released on Monday morning, Benzinga reports. They currently have a neutral rating on the financial... More of this article »
Horizon Bancorp (NASDAQ:HBNC) Upgraded to “Hold” by StockNews.com
StockNews.com upgraded shares of Horizon Bancorp (NASDAQ:HBNC – Free Report) from a sell rating to a hold rating in a research note published on Monday morning. Separately, Piper Sandler dropped their price objective on shares... More of this article »
Hasbro (NASDAQ:HAS) Given New $59.00 Price Target at DA Davidson
Hasbro (NASDAQ:HAS – Free Report) had its target price lifted by DA Davidson from $52.00 to $59.00 in a report issued on Monday morning, Benzinga reports. The brokerage currently has a neutral rating on the stock. HAS has been... More of this article »
Gentex (NASDAQ:GNTX) Lowered to “Hold” at StockNews.com
StockNews.com cut shares of Gentex (NASDAQ:GNTX – Free Report) from a buy rating to a hold rating in a report released on Monday. Other equities research analysts have also issued reports about the stock. The Goldman Sachs Group... More of this article »
Gaming and Leisure Properties (NASDAQ:GLPI) Given New $47.00 Price Target at Royal Bank of Canada
Gaming and Leisure Properties (NASDAQ:GLPI – Free Report) had its price target lowered by Royal Bank of Canada from $49.00 to $47.00 in a research note released on Monday, Benzinga reports. Royal Bank of Canada currently has... More of this article »
Guardant Health (NASDAQ:GH) Price Target Cut to $30.00 by Analysts at Canaccord Genuity Group
Guardant Health (NASDAQ:GH – Free Report) had its price target reduced by Canaccord Genuity Group from $45.00 to $30.00 in a research report report published on Monday morning, Benzinga reports. Canaccord Genuity Group currently... More of this article »
Geron (NASDAQ:GERN) Receives New Coverage from Analysts at TD Cowen
TD Cowen initiated coverage on shares of Geron (NASDAQ:GERN – Free Report) in a research report released on Monday morning, MarketBeat reports. The brokerage issued a buy rating and a $10.00 target price on the biopharmaceutical... More of this article »
Fulton Financial (NASDAQ:FULT) Upgraded to “Buy” at Janney Montgomery Scott
Janney Montgomery Scott upgraded shares of Fulton Financial (NASDAQ:FULT – Free Report) from a neutral rating to a buy rating in a research note issued to investors on Monday, Marketbeat.com reports. The firm currently has $19.50... More of this article »
First Merchants (NASDAQ:FRME) Given New $42.50 Price Target at Piper Sandler
First Merchants (NASDAQ:FRME – Free Report) had its target price increased by Piper Sandler from $41.00 to $42.50 in a report released on Monday morning, Benzinga reports. Piper Sandler currently has an overweight rating on the... More of this article »
Bank of Queensland Limited (OTCMKTS:BKQNF) Sees Significant Increase in Short Interest
Bank of Queensland Limited (OTCMKTS:BKQNF – Get Free Report) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 5,246,200 shares, an increase of 6.5% from... More of this article »
Expedia Group’s (EXPE) “Outperform” Rating Reaffirmed at Oppenheimer
Oppenheimer reaffirmed their outperform rating on shares of Expedia Group (NASDAQ:EXPE – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. They currently have a $175.00 price objective... More of this article »